About: Paul G. Richardson

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Paul G. Richardson Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

American hematologist-oncologist

Attributes	Values
rdf:type	Item
description	연구원 (ko) investigador (es) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) Hämatologe und Onkologe (de) American hematologist-oncologist (en)
rdfs:label	Paul G Richardson (nl) Paul G. Richardson (de) Paul G. Richardson (en) Paul G. Richardson (sq)
skos:prefLabel	Paul G Richardson (nl) Paul G. Richardson (de) Paul G. Richardson (en) Paul G. Richardson (sq)
name	Paul G Richardson (nl) Paul G. Richardson (de) Paul G. Richardson (en) Paul G. Richardson (sq)
given name	wds:Q87712102-EC3349FB-4DB3-41C3-B9A9-D0EEA419183C wds:Q87712102-c9fcd012-4356-fd41-44d0-86a32c641dfc
given name	Gerard Paul
instance of	wds:Q87712102-73C761D5-5721-4DF1-9FA5-3A079C86C482
instance of	Homo sapiens
award received	wds:Q87712102-bf52b387-4daf-127f-a62f-916b41ad04e7 wds:Q87712102-d9f8c36d-4f71-86a0-f11e-d7ee355f6939
award received	Fellow of the Royal College of Physicians of London Warren Alpert Foundation Prize
Google Knowledge Graph ID	wds:Q87712102-8B2F0B76-D2B9-4C82-B988-87535B98DEA0
Google Knowledge Graph ID	http://g.co/kg/g/11n06bpcfs
Google Knowledge Graph ID	/g/11n06bpcfs
skos:altLabel	Paul Richardson (de) Paul Gerard Richardson (de)
occupation	wds:Q87712102-3e608cf2-4404-f310-5ce6-b18d7ff3f2d5 wds:Q87712102-7ec66abc-481b-fa1d-bed1-c83a660e96bb wds:Q87712102-B29A284C-C753-4BCA-817D-D73653FAA18F
employer	wds:Q87712102-713eacf4-4b9d-5614-2f20-2721cda19bb4 wds:Q87712102-fe2bb49b-4f6b-e762-6dff-2f41503a23f8
sex or gender	wds:Q87712102-04eb8ad2-4a98-92a1-9b3a-25176ca9c1dd
ISNI	wds:Q87712102-29CDC330-451D-4B2E-8517-3E9BBF41E15D
VIAF ID	wds:Q87712102-127bd114-428b-7eac-8d8a-04dd2a412785
GND ID	wds:Q87712102-6db4f659-40db-6065-b156-9c0467f9b7e6
Library of Congress authority ID	wds:Q87712102-dc181017-437a-978a-8d4d-272b7b924fa9
IdRef ID	wds:Q87712102-FA6A1D90-D8D5-4162-ACA0-1B9E417BA4A5
date of birth	wds:Q87712102-79665CD3-E44E-4A63-8F33-86C1622582A9
educated at	wds:Q87712102-57791036-4928-dcf4-92af-2afdc38bc2f3
family name	wds:Q87712102-d8454b5e-4b32-072c-7e38-ed4537880b37
National Library of Israel J9U ID	wds:Q87712102-8ABF66EF-557B-4CDD-925A-213E10B89507
VIAF ID	http://viaf.org/viaf/6793073
GND ID	https://d-nb.info/gnd/1073660222
Library of Congress authority ID	http://id.loc.gov/authorities/names/n2004122832
IdRef ID	http://www.idref.fr/152967842/id
occupation	oncologist hematologist researcher
employer	Dana–Farber Cancer Institute Harvard Medical School
sex or gender	male
ISNI	0000000050448330
VIAF ID	6793073
GND ID	1073660222
Library of Congress authority ID	n2004122832
IdRef ID	152967842
date of birth	2000-01-01 00:00:00Z (xsd:dateTime)
educated at	Barts and The London School of Medicine and Dentistry
family name	Richardson
National Library of Israel J9U ID	987007369469805171
ORCID iD	wds:Q87712102-0DC595DD-68A5-4B76-8597-AC84C714C936
ORCID iD	https://orcid.org/0000-0002-7426-8865
ORCID iD	0000-0002-7426-8865
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q87712102 https://de.wikipedia.org/wiki/Paul_G._Richardson
is author of	A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancers BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth Effects of oligonucleotide N3'-->P5' thio-phosphoramidate (GRN163) targeting telomerase RNA in human multiple myeloma cells Kidney disease and multiple myeloma Evolving strategies in the initial treatment of multiple myeloma Novel biological therapies for the treatment of multiple myeloma MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo Maximizing the clinical benefit of novel therapies in multiple myeloma Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma PANORAMA 2: panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory myeloma Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial Panobinostat plus bortezomib and dexamethasone in previously treated multiple myeloma: outcomes by prior treatment Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma Bortezomib: proteasome inhibition as an effective anticancer therapy IMWG consensus on maintenance therapy in multiple myeloma Emerging trends in the clinical use of bortezomib in multiple myeloma Bortezomib: a novel therapy approved for multiple myeloma Latest advances and current challenges in the treatment of multiple myeloma Antimyeloma activity of heat shock protein-90 inhibition.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software